while circulating 25(OH)D serves as the conventional biomarker, renal 1α-hydroxylase activity determines local 1,25(OH)2D3 levels-a critical distinction highlighted by the ViRTUE-CKD tria36 where vitamin D receptor activator paricalcitol supplementation failed to alter kidney outcomes. The gene discussed is VDR; the disease is chronic kidney disease.